| Amanda N S Takai, MD | |
|
1010 Pensacola St, Honolulu, HI 96814-2118 | |
| (808) 432-2000 | |
| Not Available |
| Full Name | Amanda N S Takai |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 27 Years |
| Location | 1010 Pensacola St, Honolulu, Hawaii |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548352180 | NPI | - | NPPES |
| 00C0224810 | Other | HI | HMSA BILLING NUMBER |
| 497512-01 | Medicaid | HI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD-11081 (Hawaii) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hawaii Permanente Medical Group Inc | 7618880667 | 541 |
News Archive
China Sky One Medical, Inc., a leading fully integrated pharmaceutical company in the People's Republic of China, today announced financial results for the first quarter of 2011.
Tibotec Pharmaceuticals today announced that it has granted multiple non-exclusive licenses to generic manufacturers including Hetero Drugs Limited, Matrix Laboratories Limited (a Mylan company) of India and Aspen Pharmacare of South Africa to manufacture, market and distribute the investigational non-nucleoside reverse transcriptase inhibitor rilpivirine hydrochloride (TMC278), pending its approval for use with other antiretroviral agents in the treatment of treatment-naive HIV-1 infected adults.
Mohamed Boutjdir, PhD, professor of medicine, cell biology, and physiology and pharmacology at SUNY Downstate Medical Center, has led a study with international collaborators identifying the mechanism by which patients with various autoimmune and connective tissue disorders may be at risk for life-threatening cardiac events if they take certain anti-histamine or anti-depressant medications.
Biocides used in the food industry at sublethal doses may be endangering, rather than protecting, public health by increasing antibiotic resistance in bacteria and enhancing their ability to form harmful biofilms, according to a study published ahead of print in Applied and Environmental Microbiology. This is among the first studies to examine the latter phenomenon.
Researchers at the University of Southern California (USC) have found that inactivating a specific biomarker for aggressive prostate cancer blocks the development of prostate cancer in animal models.
› Verified 4 days ago
| Entity Name | Hawaii Permanente Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710945969 PECOS PAC ID: 7618880667 Enrollment ID: O20031106000625 |
News Archive
China Sky One Medical, Inc., a leading fully integrated pharmaceutical company in the People's Republic of China, today announced financial results for the first quarter of 2011.
Tibotec Pharmaceuticals today announced that it has granted multiple non-exclusive licenses to generic manufacturers including Hetero Drugs Limited, Matrix Laboratories Limited (a Mylan company) of India and Aspen Pharmacare of South Africa to manufacture, market and distribute the investigational non-nucleoside reverse transcriptase inhibitor rilpivirine hydrochloride (TMC278), pending its approval for use with other antiretroviral agents in the treatment of treatment-naive HIV-1 infected adults.
Mohamed Boutjdir, PhD, professor of medicine, cell biology, and physiology and pharmacology at SUNY Downstate Medical Center, has led a study with international collaborators identifying the mechanism by which patients with various autoimmune and connective tissue disorders may be at risk for life-threatening cardiac events if they take certain anti-histamine or anti-depressant medications.
Biocides used in the food industry at sublethal doses may be endangering, rather than protecting, public health by increasing antibiotic resistance in bacteria and enhancing their ability to form harmful biofilms, according to a study published ahead of print in Applied and Environmental Microbiology. This is among the first studies to examine the latter phenomenon.
Researchers at the University of Southern California (USC) have found that inactivating a specific biomarker for aggressive prostate cancer blocks the development of prostate cancer in animal models.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Amanda N S Takai, MD 1010 Pensacola St, Honolulu, HI 96814-2118 Ph: (808) 432-2000 | Amanda N S Takai, MD 1010 Pensacola St, Honolulu, HI 96814-2118 Ph: (808) 432-2000 |
News Archive
China Sky One Medical, Inc., a leading fully integrated pharmaceutical company in the People's Republic of China, today announced financial results for the first quarter of 2011.
Tibotec Pharmaceuticals today announced that it has granted multiple non-exclusive licenses to generic manufacturers including Hetero Drugs Limited, Matrix Laboratories Limited (a Mylan company) of India and Aspen Pharmacare of South Africa to manufacture, market and distribute the investigational non-nucleoside reverse transcriptase inhibitor rilpivirine hydrochloride (TMC278), pending its approval for use with other antiretroviral agents in the treatment of treatment-naive HIV-1 infected adults.
Mohamed Boutjdir, PhD, professor of medicine, cell biology, and physiology and pharmacology at SUNY Downstate Medical Center, has led a study with international collaborators identifying the mechanism by which patients with various autoimmune and connective tissue disorders may be at risk for life-threatening cardiac events if they take certain anti-histamine or anti-depressant medications.
Biocides used in the food industry at sublethal doses may be endangering, rather than protecting, public health by increasing antibiotic resistance in bacteria and enhancing their ability to form harmful biofilms, according to a study published ahead of print in Applied and Environmental Microbiology. This is among the first studies to examine the latter phenomenon.
Researchers at the University of Southern California (USC) have found that inactivating a specific biomarker for aggressive prostate cancer blocks the development of prostate cancer in animal models.
› Verified 4 days ago
Qi Zhi, NP Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2230 Liliha St Ste 104, Honolulu, HI 96817 Phone: 808-261-4476 | |
Pantea Shoja, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 1860 Ala Moana Blvd, #101, Honolulu, HI 96815 Phone: 808-921-2273 Fax: 808-921-2274 | |
Christina L Poon, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 2226 Liliha St Ste 308, Honolulu, HI 96817 Phone: 808-892-4361 | |
Dr. Jennifer Junnila Walker, MD, MPH Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Jarrett White Road, Tripler Amc, Striper Army Medical Center, Honolulu, HI 96859 Phone: 808-433-8500 Fax: 808-433-8505 | |
Dr. Lauren I Okamoto, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 347 N Kuakini St, Hpm 9, Honolulu, HI 96817 Phone: 808-523-8461 | |
Dr. John Albion Benson, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 1 Jarrett White Rd, Tripler Army Medical Center, Honolulu, HI 96859 Phone: 808-433-8850 | |
Dr. Mary Kathleen Gaynor, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1132 Bishop St, Suite 1900, Honolulu, HI 96813 Phone: 808-587-5879 |